NEURL1-AS1

Across TCGA pan-cancer cohorts, NEURL1-AS1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated NEURL1-AS1 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher NEURL1-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NEURL1-AS1 expression acts as an unfavorable survival marker, although some lineages such as BRCA and LGG show a favorable association.

CHOL, UCEC, and CESC are the cancer types where NEURL1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Quartile	All	0.246	0.773	.002	53	view →
UCEC	DFS	Tertile	All	0.512	0.677	.003	48	view →
CESC	DFS	Tertile	II,III,IV	0.614	0.802	.026	42	view →
KIRC	DFS	Tertile	IV	0.293	0.551	.024	24	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	18	view →
BRCA	DFS	Tertile	All	0.976	0.945	.041	15	view →
LGG	DFS	Quartile	All	0.498	0.323	.016	11	view →
BLCA	OS	Tertile	IV	0.263	0.605	.026	9	view →
THCA	OS	Tertile	III,IV	0.699	0.920	.026	9	view →
GBM	DFS	Quartile	All	0.108	0.263	<.001	8	view →
MESO	OS	Tertile	III,IV	0.704	0.318	.041	6	view →
READ	DFS	Tertile	II,III,IV	0.496	0.840	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

NEURL1-AS1–CHOL (OS)

Open the CHOL breakdown →